D-alpha-Cyclohexylglycine | CAS:14328-52-0

We serve D-alpha-Cyclohexylglycine CAS:14328-52-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
D-alpha-Cyclohexylglycine

CAS No: 14328-52-0
Product Name: D-α-Cyclohexylglycine
Other Name:
D-α-Cyclohexylglycine
(2S)-Amino(cyclohexyl)acetic acid
(R)-α-Aminocyclohexylacetic Acid
(2S)-Amino(cyclohexyl)acetic acid
(R)-2-Amino-2-cyclohexylacetic acid
(2R)-2-amino-2-cyclohexylacetic acid
(2R)-Amino(cyclohexyl)acetic acid
(2S)-amino(cyclohexyl)ethanoic acid
D-Cyclohexylglycine
D-2-Cyclohexylglycine
D-alpha-cyclohexylglycine
 
Density: 1.1±0.1 g/cm3
Boiling Point: 292.8±23.0 °C at 760 mmHg
Melting Point: 256ºC
Molecular Formula: C8H15NO2
Molecular Weight: 157.210
Flash Point: 130.9±22.6 °C
Exact Mass: 157.110275
PSA: 63.32000
LogP: 1.38
Vapour Pressure: 0.0±1.3 mmHg at 25°C
Index of Refraction: 1.510
 
Specification
Appearance: White to off-white powder
Assay: ≥99.0%
Specific rotation: -30°~ -32°(C=1, 1N HCl)
Isomer: ≤1.0%
Loss on drying: ≤0.50%
 
Application
Amino Acid Derivatives. Be used as pharmaceutical intermediates.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like D-α-Cyclohexylglycine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,D-alpha-cyclohexylglycine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,D-2-Cyclohexylglycine Use and application,(R)-α-Aminocyclohexylacetic Acid technical grade,usp/ep/jp grade.


Related News: Such was the apparent demand sparked by the notice that the compound formula sold out on some stores on China’s e-commerce platform Taobao.4,4'-Dibromobiphenyl manufacturer Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.3,4-Difluorophenol supplier Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.(4S,5R)-2,4-Diphenyl-4,5-dihydrooxazole-5-carboxylic acid vendor China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.